Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Agile Therapeutics

Biotech & Life Sciences · Princeton, United States · Founded 1997 · IPO 2014 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.3M
Market cap · 2026
Revenue
$51M
Latest reported FY

Investors

4 investors on Agile Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Series B+ 3 investors entered at this stage

Global footprint

Where Agile Therapeutics has talent and traffic

Web traffic by country
30 monthly visits
across markets
🏳️ Venezuela0%
🏳️ Bolivarian Republic of0%
Top 2 markets shown

See Agile Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.